Kathleen Francissen
Dr. Francissen has been dedicated to the development of advanced therapy medicinal products (ATMP) for the past several years, thus leveraging >25 years of experience in biopharmaceutical development. She serves as the Rapporteur of the ICH CGT DG, representing the Biotechnology Innovation Organization (BIO), and is responsible for leading the technical discussions.
Appearances
DateJune 12, 2024The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) brings together regulatory authorities and representatives from the pharmaceutical industry from across the globe to discuss a range of technical and scientific considerations for medicinal…Session Chair
Speakers
